FDA clears Agfa's DR system with tomo

2019 02 05 18 07 5421 Agfa Rsna 2018 400

The U.S. Food and Drug Administration (FDA) has cleared Agfa HealthCare's DR 800 multipurpose digital radiography (DR) system with tomosynthesis capability.

The system supports radiography, fluoroscopy, multislice, and advanced clinical applications, and its tomosynthesis function synthesizes slices from a single sweep, the company said. DR 800 features Agfa's Dynamic Musica image processing software, which includes tomosynthesis tools, according to the firm.

DR 800 is not yet available in Canada, Agfa said.

Page 1 of 375
Next Page